Kodak Alaris is expanding its remote service offerings with three new monitoring as a service tools that deliver cloud-based device management and optimize scanner performance. The new MPS Capture Agent, Scanner Manager and Scanner Finder Tool from Kodak Alaris enable channel partners to deliver added
- By Harshit Jain, Founder & CEO, Doceree
What’s so striking about the year 2020, other than Corona? Perhaps, it is the upsurge of digital technologies across the globe.
It goes without saying that digital methods brought some semblance of normality in our lives during the catastrophic
Heart disease has emerged as the deadliest killer in both Indian males and females. In India, nearly 52% of heart disease-related deaths occur in people below the age of 70 years.
Modern India is facing the rising burden of heart diseases as no other disease kills
Please let us know about your journey so far into the healthcare Industry?
Since beginning, I focused my education and professional training on understanding research and corporate finance. As an entrepreneur in the biotechnology industry you need to have a strong understanding of both
Fortis Healthcare hands over cheque of Rs 2.5 crore to ICMR from CSR fund in the presence of MoS Health and Family Welfare Ashwini Kumar Choubey
Leading private sector medical service provider Fortis Healthcare has handed over a cheque of Rs 2.5 crore at the initiative
On the eve of World Contraception Day, the Federation of Obstetric & Gynaecological Societies of India (FOGSI) and Bayer Zydus Pharma Pvt. Ltd. today announced their collaboration to drive increased adoption of chatbot service ‘Ask Tanu’. This digital technology will enable more women nationwide to seek credible
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pak from the United States Food and
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE：SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that its wholly-owned Japanese subsidiary has launched ILUMYA® Subcutaneous Injection 100 mg Syringe (Nonproprietary name: tildrakizumab (genetical recombination), “ILUMYA”) in Japan for the treatment of plaque psoriasis
The next step in precision medicine lies in decentralizing comprehensive biomarker testing
Envisioned to drive a new standard of cancer care, HealthCare Global Enterprises Limited (HCG Cancer Hospital Bengaluru) and Strand Life Sciences launched comprehensive genomic profiling (CGP), an approach to detect multiple actionable cancer biomarkers at ‘one
Biocon Limited (BSE: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, announced today that Anupam Jindal has been appointed as the company’s new Chief Financial Officer (CFO). Anupam will head the finance function at Biocon and be part of the Executive Leadership Team. He will